Rheumatoid Arthritis Clinical Trials in Houston

Showing 2881-2900 of 3,412 trials

Trauma Equivalency Study of the CORA® and TEG® 5000 Systems

NCT02408029

This study is being performed to obtain data about the CORA System when used in a trauma clinical setting. The CORA analyzer is a new device that is currently being tested in trauma clinical applications and is not yet cleared for this purpose by the Food and Drug Administration (FDA) for sale in the United States.

Trauma

Coramed Technologies LLC325 participantsStarted Mar 2015

South Bend, Indiana, United States • Portland, Oregon, United States • Houston, Texas, United States

COMPLETED< 1 mile

Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab

NCT01981473

The purpose of this study is to examine the relationship between anti-drug antibodies, serum drug concentrations, and clinical response for rheumatoid arthritis patients being treated with etanercept, adalimumab or infliximab.

Rheumatoid Arthritis

Pfizer605 participantsStarted Jan 2014

Glendale, Arizona, United States • Mesa, Arizona, United States • Phoenix, Arizona, United States +51 more locations

Trauma Equivalency Study of the CORA® and TEG® 5000 Systems

Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab

Rheumatoid Arthritis Trials in Other Cities

Calmer Life: Testing the Effectiveness of a Treatment for Anxiety

A Study of Alvimopan for the Management of Postoperative Ileus in Participants Undergoing Radical Cystectomy

Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors

Safety Study of Umbilical Cord Blood To Treat Pediatric Traumatic Brain Injury

Prehospital Resuscitation On Helicopter Study

ChoicesPlus: Reducing Alcohol- and Tobacco-Exposed Pregnancy

Association of Amino Acid Prevalence and Chronic Brain Injury

First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy

Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses

Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation

Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)

A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain

Natural History of Apparent Mineralocorticoid Excess Syndrome

A Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Naïve Patients With Infantile-Onset Pompe Disease

Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis

Patient-Defined Treatment Success and Preferences in Stage IV Lung Cancer Patients

Tolerance of Healthy Infants Fed Infant Formulas

104RA204 Assessment of the Safety and Efficacy of BG9924 in Rheumatoid Arthritis (RA) Participants

Other Conditions in Houston